Buparlisib (BKM120)

For research use only. Not for use in humans.

目录号:S2247 别名: NVP-BKM120 中文名称:布帕尼西

Buparlisib (BKM120) Chemical Structure

CAS No. 944396-07-0

Buparlisib (BKM120, NVP-BKM120) 是一种选择性 PI3K 抑制剂,在无细胞试验中作用于p110α/β/δ/γIC50分别为 52 nM/166 nM/116 nM/262 nM。对 VPS34,mTOR,DNAPK 的作用效果下降,而对 PI4Kβ几乎没有活性。Buparlisib 可诱导凋亡。Phase 2。

规格 价格 库存 购买数量  
10mM (1mL in DMSO) RMB 2227.95 现货
RMB 1400.12 现货
RMB 2607.65 现货
RMB 7928.28 现货
有超大折扣

今日订购,明日送达,全国免运费!

全国免费电话:400-668-6834   |   Email:info@selleck.cn

客户使用Selleck生产的Buparlisib (BKM120)发表文献194篇:

产品安全说明书

PI3K抑制剂选择性比较

生物活性

产品描述 Buparlisib (BKM120, NVP-BKM120) 是一种选择性 PI3K 抑制剂,在无细胞试验中作用于p110α/β/δ/γIC50分别为 52 nM/166 nM/116 nM/262 nM。对 VPS34,mTOR,DNAPK 的作用效果下降,而对 PI4Kβ几乎没有活性。Buparlisib 可诱导凋亡。Phase 2。
特性 BKM120是可用于口服的生物有效的PI3K抑制剂。
靶点
p110α [1]
(Cell-free assay)
p110δ [1]
(Cell-free assay)
p110β [1]
(Cell-free assay)
p110γ [1]
(Cell-free assay)
Vps34 [1]
(Cell-free assay)
52 nM 116 nM 166 nM 262 nM 2.4 μM
体外研究

BKM120作用于解除PI3K调节的细胞系,包括A2780, U87MG, MCF7和DU145时,具有抗增殖活性,GI50为0.1-0.7 nM。[1] BKM120诱导多发性骨髓瘤细胞(ARP1, ARK, MM.1S, MM1.R和U266)凋亡,导致G1期细胞增多,S期细胞减少。BKM120诱导CD138+原代MM 细胞凋亡,且作用于CD138−基质细胞时毒性较低。BKM120可引起BimS的上调和XIAP的下调。[2]BKM120作用于人类胃癌细胞系,降低mTOR下游信号,具有抗增殖活性。BKM120作用于KRAS突变的胃癌细胞系,可以增强p-ERK或 p-STAT3。BKM120 和STAT3阻断剂联用, 作用于含突变KRAS的细胞,诱导凋亡,具有协同效应,但是作用于KRAS野生型细胞没有这种效果。[3]BKM120主要通过Aurora B激酶调节有丝分裂崩坏。[4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
glioma cell lines NGrTVGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXHBNGp3PzKq MV3JR|UxRTFvMt88US=> M3roV|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{ME[1NFgxLz5{MkC2OVA5ODxxYU6=
U87 MUfBdI9xfG:|aYOgRZN{[Xl? MmjXNu69VQ>? NFHmeG04Omh? MmTCbY5lfWOnczDj[YxtKGGyb4D0c5NqeyCjbnSgZ4xm[X[nZDDQRXJRKGGwZDDjZZNx[XOnLUO= MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjB4NUC4NEc,OjJyNkWwPFA9N2F-
SNU-601 Ml7KS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEDkfng4Omh? NHP4[mZFVVOR NETK[JFKSzVyPUCuPFE3yrFyLkC2N:69VQ>? NHL1elc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkG1PVgyPCd-MkKxOVk5OTR:L3G+
SNU-1 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1nT[|czcA>? NXvkbVVOTE2VTx?= M3XKcGlEPTB;MT6wPFLDuTBwMEK4{txO M37IW|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MUW5PFE1Lz5{MkG1PVgyPDxxYU6=
SNU-668 NIDvS2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVrvfGFnPzKq MmLoSG1UVw>? NGrDbGVKSzVyPUGuOVc6yrFyLkC3OO69VQ>? NW\je|ZVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKxOVk5OTRpPkKyNVU6QDF2PD;hQi=>
AGS Ml;qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1zVc|czcA>? M4TWVmROW09? M2nmOGlEPTB;MT63NVTDuTBwMUG3{txO NHvQZnM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkG1PVgyPCd-MkKxOVk5OTR:L3G+
SNU-216 NGLPflZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH\PPYo4Omh? MVTEUXNQ MV;JR|UxRTJwNkmyxtExNjB6Mt88US=> MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjF3OUixOEc,OjJzNUm4NVQ9N2F-
SNU-5 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXy3Nog> M4mzZWROW09? NFTKO3FKSzVyPUGuN|UyyrFyLkC5Ne69VQ>? NVXMT2pwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKxOVk5OTRpPkKyNVU6QDF2PD;hQi=>
SNU-638 NFPpPIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4DTRlczcA>? MUTEUXNQ M4Xke2lEPTB;Mj6yPFLDuTBwMEWz{txO M3H0[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MUW5PFE1Lz5{MkG1PVgyPDxxYU6=
SNU-16 M1zuWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFzMWGs4Omh? NWDFNHVHTE2VTx?= MWLJR|UxRTFwNUezxtExNjByMd88US=> NV;zfXRMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKxOVk5OTRpPkKyNVU6QDF2PD;hQi=>
SNU-484 NHzHUo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVLFTWN4PzKq NV\zb5c6TE2VTx?= M1zycmlEPTB;MT63NljDuTBwMES1{txO MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjF3OUixOEc,OjJzNUm4NVQ9N2F-
SNU-620 NGG4clZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkLSO|Jp NH3id4hFVVOR NXPXTHl2UUN3ME2yMlk{QcLzMD6wNFHPxE1? MlLmQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJzNUm4NVQoRjJ{MUW5PFE1RC:jPh?=
SNU-719 NWfXO2FuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHfBc2Y4Omh? NF6wS3BFVVOR NXPyUItEUUN3ME2zMlA{P8LzMD6wN|LPxE1? NXLMc4tHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKxOVk5OTRpPkKyNVU6QDF2PD;hQi=>
MM cell lines MnPSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MY[xNO69VQ>? NVv3bpBvOjSq MVvEUXNQ M1\6S2lEPTBidnHybYV{KGGvb37nJIRq\m[ncnXueEBk\WyuIHzpcoV{KGmwIITpcYUh[W6mIHTvd4Uh\GWyZX7k[Y5k\Q>? MoHsQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ{MEe0PFUoRjJ{MkC3OFg2RC:jPh?=
ARP-1 MnTZRZBweHSxc3nzJGF{e2G7 NYHSOnhiOTEQvF2= M4\0cFI1cA>? NY\zPW1{TE2VTx?= MnK5bY5lfWOnczDNUUBk\WyuIHHwc5B1d3OrczD0bJJwfWeqIHPhd5Bie2ViYXP0bZZifGmxbh?= MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjJyN{S4OUc,OjJ{MEe0PFU9N2F-
colon cancer cell lines NFjDWnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX7hfpFmOC1zMN88US=> NIG3bJY4Omh? MX3EUXNQ NVy0SmN2UUN3ME2x{txO MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjV2M{i1O{c,OjJ3NEO4OVc9N2F-
gastric cancer cell lines NVvUN3VpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVOwMVEx|ryP MV63Nog> M3;xR2ROW09? M4X2VWlEPTB;Mj21{txO NUnDXI9kRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK1OFM5PTdpPkKyOVQ{QDV5PD;hQi=>
HCT-116/HT-29/MKN-45 MVHBdI9xfG:|aYOgRZN{[Xl? MoXFNu69VQ>? M1rnVFQ5cA>? M{S4U5NpcW[2IHnuJGczKHCqYYPl MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjV2M{i1O{c,OjJ3NEO4OVc9N2F-
HT-29 and HCT-116 MWLDZZNx[XOnIHHzd4F6 Mn3uOe69VQ>? MnKxNlRp NFXqNGdqdmS3Y3XzJINie3Cjc3WgZYN1cX[rdIm= MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjV2M{i1O{c,OjJ3NEO4OVc9N2F-
PIK3CA-mutant MCF7 NUXXdZp3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXvNcJJVT0l3ME2xOlDDuTlzbl5vwKxNTDVyPUm4NOKyOjd|bl2= NGjsXJE4Omh? Mmi2S2k2OD1zNkFCtVkydk4xvJzMSFUxRTl6MNMxNlc{dk1? M{LMOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{NkWzPVY4Lz5{Mk[1N|k3PzxxYU6=
PIK3CA-mutant MCF7 NG\jPItMcW6jc3WgRZN{[Xl? M1O1NGlEPTB;MUG0xtE{dk1? Mme2O|Jp NE\jOI5KSzVyPUGxOOKyO26PIHnuJJJm\HWlaX7nJGFsfCCyaH;zdIhwenmuYYTpc44hdGW4ZXzz MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjZ3M{m2O{c,OjJ4NUO5Olc9N2F-
MCF7-myr-Akt NFr1WnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmrGS2k2OD1{OUpCtVY5dk4xvJzMSFUx97zgMUCsNFAxdk1? M{PFRVczcA>? MUDHTVUxRTJ7OdMxOlhvVe,:jFzEOVDwxJ5zMDywNFBvVQ>? M{LiS|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{NkWzPVY4Lz5{Mk[1N|k3PzxxYU6=
Y1 cell line MorwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUSwMlHPxE1xMd88US=> Ml\sNlRp M1PZdWROW09? NFzxSIpqdmirYnn0d{A3OO,:hTDj[YxtKH[rYXLpcIl1gSCrbjDNfYMuW2O2cj30doFve2[nY4Tl[EBk\Wyucx?= M1\5RVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{NkmyPVA1Lz5{Mk[5NlkxPDxxYU6=
human NSCLC NFfaZYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWrKdG43OC53LUNOwG0> NUjaWYhJPzKq NECydJZKSzVyPUJOwG0> NX;Pd2dbRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK3PFE{QTNpPkKyO|gyOzl|PD;hQi=>
human NSCLC MlHRT4lv[XOnIFHzd4F6 M1PGdlHPxE1? MWqyOIg> Ml\UbY5pcWKrdIOgeIhmKEGtdD;tWG9TKHOrZ37hcIlv\yCyYYToe4F6KGG2IEPoJIFnfGW{IITy[YF1dWWwdB?= MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjd6MUO5N{c,OjJ5OEGzPVM9N2F-
JVM2 M1rNWmN6fG:2b4jpZ4l1gSCjc4PhfS=> NHHaWmUxNjJvMkFOwG0> NXfGcHlrPzKq NIj4b5FFVVOR MorSTWM2OD1yLkpOwG0> MmqzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN{M{i2N|koRjJ|MkO4OlM6RC:jPh?=
EHEB NXS5PXFCS3m2b4TvfIlkcXS7IHHzd4F6 MWmwMlIuOjEQvF2= M2XqUFczcA>? NWnNd4FLTE2VTx?= MlrPTWM2OD1yLkhOwG0> NYP6XGYzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOyN|g3OzlpPkKzNlM5PjN7PD;hQi=>
MEC2 NU\KfpJmS3m2b4TvfIlkcXS7IHHzd4F6 M1\MZ|AvOi1{MN88US=> NUjUWVBqPzKq NE\BTI9FVVOR MYLJR|UxRTBwN988US=> NGHKdGo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{KzPFY{QSd-MkOyN|g3Ozl:L3G+
primary B-CLL lymphocytes NIXKbHBCeG:ydH;zbZMhSXO|YYm= NEKyNpVKSzVyIH\vdkBm[WOqIIDybY1ienliY3XscEBtcW6n M1n5b|I1cA>? M331WGROW09? NY[4SVBuUUN3MP-8oFPPxE1iZn;yJIFtdCCyYYTp[Y51ew>? NEnRWWE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{KzPFY{QSd-MkOyN|g3Ozl:L3G+
primary B-CLL lymphocytes MXnLbY5ie2ViQYPzZZk> NXjldGRuUUN3MDDmc5Ih\WGlaDDwdolu[XK7IHPlcIwhdGmwZR?= MmfkNlRp NUfLN24{cW6qaXLpeJMheDdyU{\LJEYhPEVvQmCxJIV5eHKnc4Ppc44> MnTwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN{M{i2N|koRjJ|MkO4OlM6RC:jPh?=
SK-HEP1 MnLFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEDUO4MyNTJyzszN MVi3Nog> NH7xfJpFVVOR NHixSIJKSzVy78{cNe69VQ>? NX3qXI9uRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO0O|kyOzZpPkKzOFc6OTN4PD;hQi=>
786-0 NGHmXVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFnNelIyNTJyzszN NYT6RVNIPzKq MULEUXNQ MXrJR|Ux97zeMd88US=> M1nEWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NEe5NVM3Lz5{M{S3PVE{PjxxYU6=
human HCC cell lines NX\0eZJNS2WubDD2bYFjcWyrdImgZZN{[Xl? MofWNE4xODVvMd88US=> MVW0PIg> MXfJR|UxRTIQvF2= MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzR6OUm5PUc,OjN2OEm5PVk9N2F-
Huh7 NHniZWxMcW6jc3WgRZN{[Xl? MYOx{txO M1\4Z|Q5cA>? NFLF[2p{cWewaf-shYNidnSueTDy[YR2[2W|IIDoc5NxcG:{eXzheIlwdiCxZjDBb5Q> NHfhO4M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{S4PVk6QSd-MkO0PFk6QTl:L3G+
human NSCLC cell lines NWPrRnBSSXCxcITvd4l{KEG|c3H5 MmLPNE4yOjVvNN88US=> NH\J[lAzPGh? MVLEUXNQ M4nBZ2lEPTC|IILhcodmeyCocn;tJFAvPC1{zszN NVn5WFZORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1OlI1PzJpPkKzOVYzPDd{PD;hQi=>
Primary CLL cells NI\ZZlFCeG:ydH;zbZMhSXO|YYm= Ml;QNU0yOM7:TR?= Mki1OFhp NXW1THpzcW6mdXPld{BieG:ydH;zbZMhcW5iQ1zMJINmdGy|IHnu[IVx\W6mZX70JI9nKHC{b3fuc5N1cWNibXHyb4Vzew>? NXHGO3YyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO4OVA5ODdpPkKzPFUxQDB5PD;hQi=>
Primary CLL cells MVLLbY5ie2ViQYPzZZk> Mke2Nu69VQ>? M1r6Z|MxdWmw MkTJ[IVkemWjc3XkJHBKO0tiYXP0bZZqfHl? MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzh3MEiwO{c,OjN6NUC4NFc9N2F-
Primary CLL cells NXftfZBjS3m2b4TvfIlkKEG|c3H5 NFna[mgz|ryP MlTXNlRp NEHnPGdqdmS3Y3XzJINmdGxiY4n0c5RwgGmlaYT5 Mk\MQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN6NUC4NFcoRjJ|OEWwPFA4RC:jPh?=
LC-1/SQSF NHLWWGNHfW6ldHnvckBCe3OjeR?= NEPFZ4c{|ryP NYOyem86OjSq MVPEUXNQ MUfk[YNz\WG|ZTDOVmYzKHC{b4TlbY4hdGW4ZXy= NIfoN3c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{m4NFA6Oyd-MkO5PFAxQTN:L3G+
BCR-ABL M{eyeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUCwMlI2NTFyzszN MV20[C=> MVzzbYdvcW[rY3HueIx6KGmwaHnibZQh[2WubDDwdo9tcW[ncnH0bY9v NIn6co09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEK0OFYyOid-MkSyOFQ3OTJ:L3G+
T-ALL NXjpcWtISXCxcITvd4l{KEG|c3H5 MYXi[ZR4\WWwIEGuOEBidmRiNT6zJI1OKGG2IEK0bEBidmRiMD65JIFv\CB3LkWgcW0h[XRiNEjoJIlvKGSrZn\ldoVvfCClZXzsJIxqdmV? M{P1cVI1KG:{IES4bC=> NYDiS4xOTE2VTx?= MofQZYZn\WO2czD0bIUhWEl|SzDwZZRpf2G7IHnuJHQuSUyOIHPlcIwhdGmwZYO= M4j4dFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2M{GwO|M3Lz5{NEOxNFc{PjxxYU6=
H1975 NGLzeHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWewMlMuQS54zszN NXywTolmPzKq Mn7CSG1UVw>? NFvRboFKSzVyPUGuN|g2|ryP Ml7vQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR|M{e4OFYoRjJ2M{O3PFQ3RC:jPh?=
H1975 M{XXSGFxd3C2b4Ppd{BCe3OjeR?= NHnpcIcz|ryP MYKyOIg> M2jPOWROW09? NFO5VGtqdmO{ZXHz[ZMh[XCxcITvd4l{KHKjdHWgd4lodmmoaXPhcpRtgQ>? MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDN|N{i0Okc,OjR|M{e4OFY9N2F-
BON MkL3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYixMVXPxE1? MWe3Nog> NGfydpFl\WO{ZXHz[ZMh[2WubDDwdo9tcW[ncnH0bY9v MmDFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR2NEO1NlMoRjJ2NESzOVI{RC:jPh?=
BON NHLSNWJCeG:ydH;zbZMhSXO|YYm= NYrXd|BEOS13zszN M330O|I1cA>? Mn7kbY5kemWjc3XzJIFxd3C2b4Ppdy=> MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDR2M{WyN{c,OjR2NEO1NlM9N2F-
GBM NVriNIFmSXCxcITvd4l{KEG|c3H5 MXiy{txO MlnqOFhp MWPEUXNQ MnTmbY5lfWOnZDDobYdp\XJibHX2[Yx{KG:oIHHwc5B1d3OrczygZY5lKGSnY4LlZZNm\CClZXzsJJZq[WKrbHn0fS=> NU\IUIE2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS1NFA1QTJpPkK0OVAxPDl{PD;hQi=>
FaDu NGPxenpHfW6ldHnvckBCe3OjeR?= NV7VUI9mPSEQvF2= M4Hm[lI1KGh? M4HFdGROW09? NVXscGZsWmWmdXPld{BwgHmpZX6gZ49ve3WvcITpc44> MnThQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR4M{GxOFcoRjJ2NkOxNVQ4RC:jPh?=
EMT6 MV;GeY5kfGmxbjDBd5NigQ>? NVnxeoFvPSEQvF2= MV6yOEBp NHXvRmNFVVOR MYXS[YR2[2W|IH;4fYdmdiClb37zeY1xfGmxbh?= M13oXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2NkOxNVQ4Lz5{NE[zNVE1PzxxYU6=
HCT116 NEHo[WZHfW6ldHnvckBCe3OjeR?= M1n6PVUh|ryP NF3SeHAzPCCq NFrSe|NFVVOR NEPPeppT\WS3Y3XzJI95gWenbjDjc45{fW2ydHnvci=> NEXld|c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NE[zNVE1Pyd-MkS2N|EyPDd:L3G+
U87 NFLRd5JHfW6ldHnvckBCe3OjeR?= MWe1JO69VQ>? M1[3NVI1KGh? MU\EUXNQ MYnS[YR2[2W|IH;4fYdmdiClb37zeY1xfGmxbh?= NXT0N3VURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS2N|EyPDdpPkK0OlMyOTR5PD;hQi=>
Saos-2 M2PUR2Z2dmO2aX;uJGF{e2G7 M4HUUlUxKM7:TR?= MYe0PEBp MULJcohq[mm2czDj[YxtKGmwdnHzbY9v M{nJOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{K3OlYxLz5{NEeyO|Y3ODxxYU6=
MG-63 NVnoWnp5TnWwY4Tpc44hSXO|YYm= NHSxZno2OCEQvF2= M1HJ[|Q5KGh? NGL2O3FKdmirYnn0d{Bk\WyuIHnueoF{cW:w NILQUYw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEeyO|Y3OCd-MkS3Nlc3PjB:L3G+
SJSA-1 M{LSbmZ2dmO2aX;uJGF{e2G7 NIHaXWQ2OCEQvF2= NET5U4k1QCCq MoDnTY5pcWKrdIOgZ4VtdCCrbo\hd4lwdg>? NVu0eW5oRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3Nlc3PjBpPkK0O|I4PjZyPD;hQi=>
Saos-2 NY\hR2JrTnWwY4Tpc44hSXO|YYm= MoHNOVAh|ryP MlPVOFghcA>? MoPpTY5pcWKrdIOgcYF1emm6IH3leIFtdG:ycn;0[Ylv[XOnLUKg[ZhxemW|c3nvci=> MlPyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5Mke2OlAoRjJ2N{K3OlYxRC:jPh?=
MG-63 NEjVb4tHfW6ldHnvckBCe3OjeR?= MWG1NEDPxE1? M1ztS|Q5KGh? NGm1eGVKdmirYnn0d{Bu[XS{aYigcYV1[Wyub4Dyc5RmcW6jc3WtNkBmgHC{ZYPzbY9v MmrIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5Mke2OlAoRjJ2N{K3OlYxRC:jPh?=
SJSA-1 NVnZXopKTnWwY4Tpc44hSXO|YYm= MYG1NEDPxE1? M2L2dlQ5KGh? NUjl[odSUW6qaXLpeJMhdWG2cnn4JI1mfGGubH;wdo91\WmwYYPlMVIh\XiycnXzd4lwdg>? NUHURm1ORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3Nlc3PjBpPkK0O|I4PjZyPD;hQi=>
Saos-2 NX\V[3ZPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmrLOVAh|ryP M4TOOlQ5KGh? Mnm0TY5pcWKrdIOgZ4VtdCC4aXHibYxqfHl? NIKwZ|E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEeyO|Y3OCd-MkS3Nlc3PjB:L3G+
MG-63 NV7zVZJ7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHrMSY02OCEQvF2= M{XrdlQ5KGh? NF;USoRKdmirYnn0d{Bk\WyuII\pZYJqdGm2eR?= NXnXd4ZuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3Nlc3PjBpPkK0O|I4PjZyPD;hQi=>
SJSA-1 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWq1NEDPxE1? MnrLOFghcA>? MWTJcohq[mm2czDj[YxtKH[rYXLpcIl1gQ>? NVS1dGs5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3Nlc3PjBpPkK0O|I4PjZyPD;hQi=>
LN18 NXPKb|l4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXnydoluOjBizszN NHewcVg4OiCq MXnEUXNQ MWTJR|UxRDVizszN MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDd2MUC3OEc,OjR5NEGwO|Q9N2F-
LN229 NIDwdXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFft[YEzOCEQvF2= MYS3NkBp MoDwSG1UVw>? MnXKTWM2ODx3IN88US=> MoHkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NEGwO|QoRjJ2N{SxNFc1RC:jPh?=
LNZ308 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYGyNEDPxE1? M1PJR|czKGh? NEDLTlZFVVOR MXfJR|UxRDVizszN NUnLVWdYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3OFExPzRpPkK0O|QyODd2PD;hQi=>
T98G M2HFXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2PHflIxKM7:TR?= NE\JSoM4OiCq NHPQU3BFVVOR MULJR|UxRDVizszN NXvUVWxWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3OFExPzRpPkK0O|QyODd2PD;hQi=>
U87 Ml7jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYK5fWxkOjBizszN MXK3NkBp NXfGelZKTE2VTx?= NXrob3lbUUN3MEy1JO69VQ>? M3PZNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{SxNFc1Lz5{NEe0NVA4PDxxYU6=
LN18 NHL1b3JHfW6ldHnvckBCe3OjeR?= MorlOUDPxE1? MUOyOEBp MoK5SG1UVw>? NYf2[ItMUW6qaXLpeJMheGixc4Doc5J6dGG2aX;uJI9nKEGNVB?= Mln4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NEGwO|QoRjJ2N{SxNFc1RC:jPh?=
LNZ308 MYjGeY5kfGmxbjDBd5NigQ>? NEfCTmI2KM7:TR?= NV:yPVVGOjRiaB?= NYTJdYZ[TE2VTx?= M373cmlvcGmkaYTzJJBpd3OyaH;yfYxifGmxbjDv[kBCU1R? MkXSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NEGwO|QoRjJ2N{SxNFc1RC:jPh?=
MDA-MB-175 NGnnSldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVmxJO69VQ>? NWO3fpN{PSCm NFP2fJJFVVOR NHG5co5KSzVyPEGg{txO MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
MDA-MB-134 M{XMcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV6xJO69VQ>? NFTufGc2KGR? MX;EUXNQ NUXZT|FqUUN3MEyxJO69VQ>? M4\oeVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEe5O|k3Lz5{NEi3PVc6PjxxYU6=
HCC1500 M1r5SWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFvDbGEyKM7:TR?= MkTNOUBl NGHCOYJFVVOR NVHZUodQUUN3MEyxJO69VQ>? NUXtZ|VxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4O|k4QTZpPkK0PFc6Pzl4PD;hQi=>
EFM-19 NXLJVJRHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH3JTHcyKM7:TR?= MlfSOUBl MlfESG1UVw>? NYfpcoZ6UUN3MEyxJO69VQ>? MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
ZR-75-30 NYDqdY83T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXP4OIo6OSEQvF2= NFvoUHY2KGR? MYLEUXNQ MV3JR|UxRDFizszN M2O3SVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEe5O|k3Lz5{NEi3PVc6PjxxYU6=
MDA-MB-361 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXnCNWZkOSEQvF2= MX61JIQ> NVjGU5ROTE2VTx?= MonWTWM2ODxzIN88US=> MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
T-47D NWfrXXFxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGHZb5IyKM7:TR?= NH;LSoc2KGR? M1XiSWROW09? NIrER5NKSzVyPEGg{txO NIPzR5c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
SK-BR-3 NEPoeHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mk\DNUDPxE1? NUTmTGw1PSCm MljKSG1UVw>? NV\sPYRGUUN3MEyxJO69VQ>? NFL1e3Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
UACC-732 NYnJU3ZuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFrZ[40yKM7:TR?= MX[1JIQ> MYjEUXNQ NIDneolKSzVyPEGg{txO NFSyWYM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
BT-474 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV3LenY2OSEQvF2= NITlRYM2KGR? M1y4RmROW09? MVzJR|UxRDFizszN MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
HCC202 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2WzUlEh|ryP M4WwZlUh\A>? NH7TPIlFVVOR NILUOlBKSzVyPEGg{txO MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
MCF7 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEe5ZlMyKM7:TR?= MVK1JIQ> NHPYR25FVVOR MV\JR|UxRDFizszN NX7PcphxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4O|k4QTZpPkK0PFc6Pzl4PD;hQi=>
MDA-MB-415 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIPpXlIyKM7:TR?= M{jrO|Uh\A>? MUXEUXNQ NX\EOlVKUUN3MEyxJO69VQ>? M{jRR|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEe5O|k3Lz5{NEi3PVc6PjxxYU6=
MDA-MB-453 M3P0VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MorUNUDPxE1? NHv5fGM2KGR? NG\ubYxFVVOR MoLHTWM2ODxzIN88US=> MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
ZR-75-1 NEizOINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIm0[5QyKM7:TR?= MY[1JIQ> MVTEUXNQ NEK2R|VKSzVyPEGg{txO MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
HCC38 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXixJO69VQ>? MkfyOUBl MkXQSG1UVw>? MYHJR|UxRDFizszN MnnWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6N{m3PVYoRjJ2OEe5O|k3RC:jPh?=
HCC1419 NY\Te2FwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYGxJO69VQ>? MYq1JIQ> Mnn1SG1UVw>? NWfqepI4UUN3MEyxJO69VQ>? M3T2PVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEe5O|k3Lz5{NEi3PVc6PjxxYU6=
UACC-812 M4HGWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVO0S|VPOSEQvF2= NH3iWno2KGR? Mn;vSG1UVw>? NVPBRml7UUN3MEyxJO69VQ>? M{[5XFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEe5O|k3Lz5{NEi3PVc6PjxxYU6=
HCC1187 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEDkXngyKM7:TR?= NWDjdpJXPSCm NVj2b|lGTE2VTx?= M1fPNmlEPTB:MTFOwG0> MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
KPL-1 NGWxRmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnzhNUDPxE1? NVLJUYJlPSCm NILPemFFVVOR NEGxVnRKSzVyPEGg{txO MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
SUM-225 NVHldFVNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NX75R4JCOSEQvF2= Mo\WOUBl NGXXNIVFVVOR NID2O2ZKSzVyPEGg{txO MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
EFM-192A MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF3Qb5YyKM7:TR?= Ml;aOUBl M1TMbWROW09? M2ntdWlEPTB:MTFOwG0> NVK1N|FyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4O|k4QTZpPkK0PFc6Pzl4PD;hQi=>
JIMT-1 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXmxJO69VQ>? MYi1JIQ> MV\EUXNQ NGTMZ2dKSzVyPEGg{txO M{fBUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEe5O|k3Lz5{NEi3PVc6PjxxYU6=
HCC1143 M3m1R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NU\l[FJZOSEQvF2= M3TzPVUh\A>? MWDEUXNQ NYLFR5l4UUN3MEyxJO69VQ>? MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
HCC2218 M1zSU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVKxJO69VQ>? NWrTTlNIPSCm MmrqSG1UVw>? M4fCfGlEPTB:MTFOwG0> NFTp[4M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
MDA-MB-468 NH\tOppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWexJO69VQ>? Mn;FOUBl NVi5dmh4TE2VTx?= M4fvRmlEPTB:MTFOwG0> NUKyZZgzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4O|k4QTZpPkK0PFc6Pzl4PD;hQi=>
BT-20 NEXGNFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmHtNUDPxE1? MYm1JIQ> MUDEUXNQ MVvJR|UxRDFizszN NFzkbZk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
MDA-MB-435 NGrXfWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1XYbVEh|ryP NUHyNIxGPSCm Mn3rSG1UVw>? M1PycWlEPTB:MTFOwG0> NX;BeIhDRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4O|k4QTZpPkK0PFc6Pzl4PD;hQi=>
BT-549 MoPMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV;OUGFLOSEQvF2= NUC1VFhbPSCm M2L4[2ROW09? MlvFTWM2ODxzIN88US=> NGHudYo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
HCC1806 NFjKZnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M331TFEh|ryP NELzTGg2KGR? M3HJRWROW09? M3fVU2lEPTB:MTFOwG0> NIHBUpQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
HCC1937 M4P3cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFH2UXEyKM7:TR?= M1v5UlUh\A>? NXjrc4dLTE2VTx?= Moj0TWM2ODxzIN88US=> MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
Hs578T NUj2d4pMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3rjPFEh|ryP Mn7BOUBl NX71UIt5TE2VTx?= NFfQVHRKSzVyPEGg{txO NHjRRpI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
MCF7 NYW2OpVOS3m2b4TvfIlkKEG|c3H5 NVTPcWhXPzJiaB?= NUmyXYRYTE2VTx?= MmXLR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUWNHPyClZXzsd{BmgHC{ZYPzbY5oKFCLM1vhcJBp[SCHNUS1T{BufXSjboSge4l1cCCJSUWwJI9nKDBwMECwNVU5KM7:TR?= NXGxUo9lRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFAzPjZpPkK0PVAxOjZ4PD;hQi=>
DU145 MkP6R5l1d3SxeHnjJGF{e2G7 NHvkXIU4OiCq NXXWOHZTTE2VTx?= MnvnR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gSHUyPDViY3XscJMh\XiycnXzd4lv\yCOS1KxJI12fGGwdDD3bZRpKEeLNUCgc4YhOC5yMEC0N|Uh|ryP NWXxT494RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFAzPjZpPkK0PVAxOjZ4PD;hQi=>
A2780 NH72WXdEgXSxdH;4bYMhSXO|YYm= MnLoO|IhcA>? NHLT[o9FVVOR MoDqR5l1d3SxeHnjbZR6KGGpYXnud5QhWFSHTj3k[YZq[2mnboSgbJVu[W5iQUK3PFAh[2WubIOge4l1cCCJSUWwJI9nKDBwMECwOlM2KM7:TR?= NGXUfI49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEmwNFI3Pid-MkS5NFAzPjZ:L3G+
U87MG MnvFR5l1d3SxeHnjJGF{e2G7 MmD4O|IhcA>? NVvH[IZkTE2VTx?= MWTDfZRwfG:6aXPpeJkh[WejaX7zeEBRXEWQLXTl[olkcWWwdDDoeY1idiCXOEfNS{Bk\WyuczD3bZRpKEeLNUCgc4YhOC5yMEC2PVgh|ryP MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEK2Okc,OjR7MECyOlY9N2F-
A2780 NF;GR49HfW6ldHnvckBCe3OjeR?= M1yzZlEhcA>? MUnEUXNQ NYHrNWdDUW6qaXLpeIlwdiCxZjDQTVNMNW2nZHnheIVlKEGNVDDT[ZI1PzNicHjvd5Bpd3K7bHH0bY9vKHerdHigSWM2OCCxZjCwMlA2PSEQvF2= M4fj[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUCwNlY3Lz5{NEmwNFI3PjxxYU6=
DU145 MmrUSpVv[3Srb36gRZN{[Xl? MYmxJIg> MlTsSG1UVw>? MoPvTY5pcWKrdHnvckBw\iCSSUPLMY1m\GmjdHXkJGFMXCCVZYK0O|MheGixc4Doc5J6dGG2aX;uJIlvKGi3bXHuJGRWOTR3IHPlcIx{KGijcnLvdolv\yCOS1KxJI12fGG2aX;uJJdqfGhiRVO1NEBw\iByLkC3N{DPxE1? MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEK2Okc,OjR7MECyOlY9N2F-
A2780 M2HmPGZ2dmO2aX;uJGF{e2G7 MW[xJIg> NV;pcFJHTE2VTx?= MkLOTY5pcWKrdHnvckBw\iCSSUPLMY1m\GmjdHXkJGFMXCCVZYK0O|MheGixc4Doc5J6dGG2aX;uJIlvKFCWRV6t[IVncWOrZX70JIh2dWGwIFGyO|gxKGOnbHzzJJdqfGhiRVO1NEBw\iByLkC3OEDPxE1? MnXmQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7MECyOlYoRjJ2OUCwNlY3RC:jPh?=
MCF7 M1fRUGZ2dmO2aX;uJGF{e2G7 M4rPUVEhcA>? NHzUd2NFVVOR MWDJcohq[mm2aX;uJI9nKFCLM1vhcJBp[SCHNUS1T{BufXSjboStcYVlcWG2ZXSgRWtVKFOnckS3N{BxcG:|cHjvdplt[XSrb36ge4l1cCCHQ{WwJI9nKDBwMTFOwG0> NX33UGk3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFAzPjZpPkK0PVAxOjZ4PD;hQi=>
U87MG M4jQNGZ2dmO2aX;uJGF{e2G7 NX;Yb2ZUOSCq NHX3XYRFVVOR M17VR2lvcGmkaYTpc44hd2ZiUFmzT{1u\WSrYYTl[EBCU1RiU3XyOFc{KHCqb4PwbI9zgWyjdHnvckBqdiCSVFXOMYRm\mmlaXXueEBpfW2jbjDVPFdOTyClZXzsd{B4cXSqIFXDOVAhd2ZiMD6xN{DPxE1? NVzaWoY4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFAzPjZpPkK0PVAxOjZ4PD;hQi=>
A2780 NUi5Uo1ST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV7tXXZiPzJiaB?= Ml\DSG1UVw>? NUXsenlbTUN3ME2wMlUzKM7:TR?= M2TBc|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUCwNlY3Lz5{NEmwNFI3PjxxYU6=
Huh7 NIT3W4hHfW6ldHnvckBCe3OjeR?= MUKxJO69VQ>? NWmwT3hLOSCq MlK1SG1UVw>? NILtTWhKdmirYnn0d{BxcG:|cHjvdplt[XSrb36gc4YhSUuWIHH0JHNmejR5NB?= NX;RNml4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWwNFQ1ODNpPkK1NFA1PDB|PD;hQi=>
BNL M3;DZ2Z2dmO2aX;uJGF{e2G7 M3vQTFEh|ryP NWrj[lZEOSCq MWrEUXNQ M3LzUmlvcGmkaYTzJJBpd3OyaH;yfYxifGmxbjDv[kBUPg>? NFLW[Is9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUCwOFQxOyd-MkWwNFQ1ODN:L3G+
BON-1 M4jBS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVq1NFAhdk1? NECxbI8yOCCm MljBSG1UVw>? NHu0T|RKdmirYnn0d{Bk\WyuIHfyc5d1cA>? NYW3[FVpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWwNlYzQTJpPkK1NFI3Ojl{PD;hQi=>
BON-1 MoLySpVv[3Srb36gRZN{[Xl? M{TNfVUxOCCwTR?= NIfTOXU1KGh? NUnEXlExTE2VTx?= MlW3TY5pcWKrdIOgdIhwe3Cqb4L5cIF1cW:wIH;mJGFMXCCjdDDUbJI{ODhiYX7kJHNmejR5Mx?= NG\vZnU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUCyOlI6Oid-MkWwNlYzQTJ:L3G+
QGP-1 MUHGeY5kfGmxbjDBd5NigQ>? M4XHTVUxOCCwTR?= NWPPS21uPCCq M3TKNGROW09? MXTJcohq[mm2czDwbI9{eGixconsZZRqd25ib3[gRWtVKGG2IGTodlMxQCCjbnSgV4VzPDd| M2X2clxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MEK2NlkzLz5{NUCyOlI6OjxxYU6=
HCT-15 MUDBdI91d3OrczDBd5NigQ>? NXfmXZJbOTBizszN MYW0PEBp MkCxSG1UVw>? MWjJcoR2[2W|IHHwc5B1d3OrczDpckBJS1RvMUWgZ4VtdHNiaHHyZo92emmwZzDQTWs{S0FiaH;0d5BwfCCvdYTheIlwdg>? NV\2clBURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOVIzPDVpPkK1NVUzOjR3PD;hQi=>
HCT-116 NYfJbGQySXCxdH;zbZMhSXO|YYm= NWHUXGFLOTBizszN NIqzZnc1QCCq NXT1fnFNTE2VTx?= NVX3cmRPUW6mdXPld{BieG:ydH;zbZMhcW5iSFPUMVEyPiClZXzsd{Bp[XKkb4XybY5oKFCLS{PDRUBpd3S|cH;0JI12fGG2aX;u MkXCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzNUKyOFUoRjJ3MUWyNlQ2RC:jPh?=
NCI-H460 MYHBdI91d3OrczDBd5NigQ>? MnHUNVAh|ryP Mke0OFghcA>? MmDzSG1UVw>? MlvLTY5lfWOnczDhdI9xfG:|aYOgbY4hVkOLLVi0OlAh[2WubIOgbIFz[m:3cnnu[{BRUUt|Q1GgbI91e3CxdDDteZRifGmxbh?= NUnrXYMxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOVIzPDVpPkK1NVUzOjR3PD;hQi=>
SKOV-3 NV\hW4JUSXCxdH;zbZMhSXO|YYm= NHr2RZkyOCEQvF2= MkDjOFghcA>? NUG5O3FCTE2VTx?= M1ixT2lv\HWlZYOgZZBweHSxc3nzJIlvKFONT2[tN{Bk\WyuczDoZZJjd3W{aX7nJHBKUzOFQTDoc5R{eG:2IH31eIF1cW:w NHLwd3U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG1NlI1PSd-MkWxOVIzPDV:L3G+
BSY-1 M17RbGFxd3Sxc3nzJGF{e2G7 NGHIU3gyOCEQvF2= Mn3tOFghcA>? MoHBSG1UVw>? Ml3qTY5lfWOnczDhdI9xfG:|aYOgbY4hSlO\LUGgZ4VtdHNiaHHyZo92emmwZzDQTWs{S0FiaH;0d5BwfCCvdYTheIlwdg>? MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF3MkK0OUc,OjVzNUKyOFU9N2F-
MKN-1 MmDDRZBwfG:|aYOgRZN{[Xl? M1;I[|ExKM7:TR?= NFnlRWw1QCCq NGLiUIFFVVOR NYK1XpdDUW6mdXPld{BieG:ydH;zbZMhcW5iTVvOMVEh[2WubIOgbIFz[m:3cnnu[{BRUUt|Q1GgbI91e3CxdDDteZRifGmxbh?= MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF3MkK0OUc,OjVzNUKyOFU9N2F-
NCI-H522 MWLBdI91d3OrczDBd5NigQ>? NUnub4VpOTBizszN M17uWlQ5KGh? M1PXVGROW09? Mn;sTY5lfWOnczDhdI9xfG:|aYO= M2nqVFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUWyNlQ2Lz5{NUG1NlI1PTxxYU6=
OVCAR-3 MX3BdI91d3OrczDBd5NigQ>? NYiwXYlmOTBizszN NU\uXFJmPDhiaB?= MWTEUXNQ M3XSbGlv\HWlZYOgZZBweHSxc3nz M{P6RlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUWyNlQ2Lz5{NUG1NlI1PTxxYU6=
HBC-5 M2DYe2Fxd3Sxc3nzJGF{e2G7 MlrSNVAh|ryP MX60PEBp M1fWZ2ROW09? MWPJcoR2[2W|IHHwc5B1d3Orcx?= Mmi1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzNUKyOFUoRjJ3MUWyNlQ2RC:jPh?=
RXF-631L MnzuRZBwfG:|aYOgRZN{[Xl? MnvuNVAh|ryP MUm0PEBp NF\teWpFVVOR Mn7YTY5lfWOnczDhdI9xfG:|aYO= MoCyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzNUKyOFUoRjJ3MUWyNlQ2RC:jPh?=
MKN-45 NF7RfI5CeG:2b4Ppd{BCe3OjeR?= M4LuO|ExKM7:TR?= NYnBXXJyPDhiaB?= NX7pbVRRTE2VTx?= M4fMSGlv\HWlZYOgZZBweHSxc3nz M1j4NlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUWyNlQ2Lz5{NUG1NlI1PTxxYU6=
LNCaP MlLGSpVv[3Srb36gRZN{[Xl? NVnKVmVKOSEQvF2= NF;3cJhUfXCycnXzd4V{KHBvQVvUJIxmfmWucx?= M3;Ye|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3M{[wO|k6Lz5{NUO2NFc6QTxxYU6=
LNCaP95 NHvRPXZHfW6ldHnvckBCe3OjeR?= MYKxJO69VQ>? MVrTeZBxemW|c3XzJJAuSUuWIHzleoVtew>? NX7vUGRtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWzOlA4QTlpPkK1N|YxPzl7PD;hQi=>
A549 M3rPdWZ2dmO2aX;uJGF{e2G7 Moq5OVAxKG6P NYS0N|hjPDhiaB?= M3TmXGROW09? M{GydmlvcGmkaYTzJGFsfCCjY4TpeoF1cW:w NWW0OVRURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW5N|czQTlpPkK1PVM4Ojl7PD;hQi=>
A549 M2\hUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVHlSYRCOSEQvF2= NGX3fFQ4OiCq M2LDW2ROW09? MWXJcohq[mm2czDj[YxtKGe{b4f0bC=> NVHWUng4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW5N|czQTlpPkK1PVM4Ojl7PD;hQi=>
H522 M3jESmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3zFOVEh|ryP MVu3NkBp NIOyfnZFVVOR NF\MV5ZKdmirYnn0d{Bk\WyuIHfyc5d1cA>? MoXIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV7M{eyPVkoRjJ3OUO3Nlk6RC:jPh?=
SKMES-1 MWDDfZRwfG:6aXOgRZN{[Xl? M2\RWFEh|ryP MYq3NkBp MVTJcoR2[2W|IHPlcIwh\GWjdHi= NEK2RnI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkCxN|MyQCd-Mk[wNVM{OTh:L3G+
H596 Mn7WSpVv[3Srb36gRZN{[Xl? MkfENUDPxE1? M4SzcWlueGGrcoOgZ4VtdCCvaXfyZZRqd25? Mn\iQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZyMUOzNVgoRjJ4MEGzN|E5RC:jPh?=
HCC2450 M37ISmZ2dmO2aX;uJGF{e2G7 Mn\DNUDPxE1? M33iS2lueGGrcoOgZ4VtdCCrbo\hd4lwdg>? NX\l[nhqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[wNVM{OThpPkK2NFE{OzF6PD;hQi=>
HCT116 NUnG[FV3SW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= M{DEclczKGi{cx?= NVTvV49[SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIR3QyOTZiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvPDhizszNMi=> M{XPUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3N{[1PVA6Lz5{NUe2OVkxQTxxYU6=
MCF7 NGPTdIZCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MVy3NkBpenN? NIjUPHFCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IEGg{txONg>? MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTd4NUmwPUc,OjV5NkW5NFk9N2F-
U87MG NXW5ZZRpSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NI\rd5o4OiCqcoO= MVrBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFV6N13HJINmdGy|IHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSBzLk[0JO69VS5? Mmj1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV5NkW5NFkoRjJ3N{[1PVA6RC:jPh?=
A549 NEXZWoxCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MljVO|IhcHK| M2LQXmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUW0PUBk\WyuczDh[pRmeiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iMj6wO{DPxE1w NVTEfoVFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW3OlU6ODlpPkK1O|Y2QTB7PD;hQi=>
HeLa MnXwRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NXTLdIFMPzJiaILz NEXpSJFCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjlUIEh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IESuN|Qh|ryPLh?= MkPRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV5NkW5NFkoRjJ3N{[1PVA6RC:jPh?=
HCT116 M{Pwc2Z2dmO2aX;uJIF{e2G7 Mnn5NVAhfU1? M4jQRVEhcHJ? MUXJcohq[mm2aX;uJI9nKFCLM1uvRYt1KGmwIHj1cYFvKEiFVEGxOkBk\WyuczDhd5Nme3OnZDDhd{BCc3RicHjvd5Bpd3K7bHH0bY9vKGG2IEGwJJVOKGGodHXyJFEhcHJiYomgW4V{fGW{bjDicI91fGmwZzDhcoFtgXOrcx?= Ml3sQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV5NkW5NFkoRjJ3N{[1PVA6RC:jPh?=
A2058 melanoma MorpR4VtdCCleXPs[UBie3OjeR?= M3;4V|UhfU1? MWqyOEBpenN? M1fz[mNmdGxiY4njcIUh[XK{ZYP0JIlvKGi3bXHuJGEzODV6IH3lcIFvd22jIHPlcIx{KGG|c3Xzd4VlKGG|IHHjZ5VufWyjdHnvckBifCCVdXLHNUBxcGG|ZTDheEA2KHWPIHHmeIVzKDJ2IHjyd{BjgSCycn;wbYRqfW1iaX;kbYRmKHO2YXnubY5oKGKjc3XkJGZCS1NiYX7hcJl{cXN? Mn23QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh6Mkm1PVIoRjJ6OEK5OVkzRC:jPh?=
A2058 melanoma NVGwd2hiS2WubDDjfYNt\SCjc4PhfS=> M1XCbVUhfU1? NHLoZ3UzPCCqcoO= MWLD[YxtKGO7Y3zlJIFzemW|dDDpckBpfW2jbjDBNlA2QCCvZXzhco9u[SClZXzsd{Bie3Onc4Pl[EBieyCjY3P1cZVt[XSrb36gZZQhTzJxTTDwbIF{\SCjdDC1JJVOKGGodHXyJFI1KGi{czDifUBxem:yaXTpeY0hcW:maXTlJJN1[WmwaX7nJIJie2WmIF\BR3Mh[W6jbInzbZM> MXu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDh{OUW5Nkc,Ojh6Mkm1PVI9N2F-
SKOV3 NXy4S|FZS2WubDDjfYNt\SCjc4PhfS=> MV6yJJVO MYmyOEBpenN? MkjQR4VtdCCleXPs[UBienKnc4SgbY4hcHWvYX6gV2tQXjNiY3XscJMh[XO|ZYPz[YQh[XNiYXPjeY12dGG2aX;uJIF1KEd{L12gdIhie2ViYYSgNkB2VSCjZoTldkAzPCCqcoOgZpkheHKxcHnkbZVuKGmxZHnk[UB{fGGrbnnu[{Bj[XOnZDDGRWNUKGGwYXz5d4l{ NEXTV4o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEiyPVU6Oid-Mki4Nlk2QTJ:L3G+
SKOV3 NHzXeGtE\WyuIHP5Z4xmKGG|c3H5 NVXmWFF7OiC3TR?= NX7lW5N1OjRiaILz MXzD[YxtKGO7Y3zlJIFzemW|dDDpckBpfW2jbjDTT29XOyClZXzsd{Bie3Onc4Pl[EBieyCjY3P1cZVt[XSrb36gZZQhW3WkR{GgdIhie2ViYYSgNkB2VSCjZoTldkAzPCCqcoOgZpkheHKxcHnkbZVuKGmxZHnk[UB{fGGrbnnu[{Bj[XOnZDDGRWNUKGGwYXz5d4l{ NYTN[mR5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki4Nlk2QTJpPkK4PFI6PTl{PD;hQi=>
MDA-MB-231 M1zn[mN6fG:2b4jpZ4l1gSCjc4PhfS=> NIj5O5A4OiCqcoO= NEj3d2FEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOTEFvTVKtNlMyKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTCxMlg5KM7:TT6= MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTFyN{SyPUc,OjlzMEe0Nlk9N2F-
PC3 MkTaR5l1d3SxeHnjbZR6KGG|c3H5 NV72WHdvPzJiaILz NWftRWNlS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hWEN|IHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUA2NjN2IN88UU4> MljpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjlzMEe0NlkoRjJ7MUC3OFI6RC:jPh?=
T47D NXzlPYFnS3m2b4TvfIlkcXS7IHHzd4F6 NI\2[Io4OiCqcoO= NITUcYdEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBVPDeGIHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUA3Njl{IN88UU4> MmrTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjlzMEe0NlkoRjJ7MUC3OFI6RC:jPh?=
MCF7 MoLzR5l1d3SxeHnjbZR6KGG|c3H5 M{LT[|czKGi{cx?= NVnKWlN1S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVUOINzDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOTFwMEWg{txONg>? NXj5[WpsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkmxNFc1OjlpPkK5NVA4PDJ7PD;hQi=>
TC32 MkWydWhVWyCjc4PhfS=> NWDmco5leUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGTDN|Ih[2WubIO= NUT4e4VZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
A673 NGixcXpyUFSVIHHzd4F6 MUHxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSTZ5MzDj[Yxtew>? MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
DAOY MWXxTHRUKGG|c3H5 Mom3dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKESDT2mgZ4VtdHN? MmDIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
Saos-2 M2T6R5FJXFNiYYPzZZk> MXnxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW2Gxcz2yJINmdGy| NXWyRlBFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
BT-37 MorpdWhVWyCjc4PhfS=> NYDLbWpveUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFLUMVM4KGOnbHzz MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
RD NIn1cVdyUFSVIHHzd4F6 MnPzdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFKGIHPlcIx{ MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
SK-N-SH M4jaPZFJXFNiYYPzZZk> MnjBdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFONLV6tV2gh[2WubIO= MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
BT-12 M3zoeJFJXFNiYYPzZZk> M1nOdpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCEVD2xNkBk\Wyucx?= NUX0b3JKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
MG 63 (6-TG R) NIDTS4hyUFSVIHHzd4F6 NU\VNVE3eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IF3HJFY{KCh4LWTHJHIqKGOnbHzz MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
NB1643 M1vVWJFJXFNiYYPzZZk> NF7IU5dyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiTlKxOlQ{KGOnbHzz MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
OHS-50 NV3ucHhCeUiWUzDhd5NigQ>? MoHndWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE:KUz21NEBk\Wyucx?= MofVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SK-N-SH MofxdWhVWyCjc4PhfS=> M3XiWJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJHNMNU5vU1igZ4VtdHN? M3HNSlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
Rh41 NVLjS2ZqeUiWUzDhd5NigQ>? MUHxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWmh2MTDj[Yxtew>? Ml:yQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
A673 M3e1XJFJXFNiYYPzZZk> M{LmW5FJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJGE3PzNiY3XscJMq NYCye494RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh30 NYG1Z|dEeUiWUzDhd5NigQ>? MXzxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWmh|MDDj[Yxtew>? NF3xRoo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
MG 63 (6-TG R) MorvdWhVWyCjc4PhfS=> MX3xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBEd26oaYLtZZRwenlic3Py[YVvKG[xcjDNS{A3OyBqNj3US{BTMSClZXzsdy=> NFLtXYI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
Rh30 MorYdWhVWyCjc4PhfS=> M3;ZcpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJHJpOzBiY3XscJM> NGL0VWk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
U-2 OS MYTxTHRUKGG|c3H5 NV\nOVdNeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiQ3;u[olzdWG2b4L5JJNkemWnbjDmc5IhXS1{IF;TJINmdGy| MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
Rh41 MX7xTHRUKGG|c3H5 MX\xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBEd26oaYLtZZRwenlic3Py[YVvKG[xcjDSbFQyKGOnbHzz MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
RD Mkn3dWhVWyCjc4PhfS=> MY\xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBEd26oaYLtZZRwenlic3Py[YVvKG[xcjDSSEBk\Wyucx?= M37vUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
SJ-GBM2 MV\xTHRUKGG|c3H5 M3nWRZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSj3HRm0zKGOnbHzz MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
SK-N-MC MWLxTHRUKGG|c3H5 NYPmZXNQeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uVUNiY3XscJM> NVvqXod4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
NB-EBc1 M3XveZFJXFNiYYPzZZk> NEjjZ5FyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiTlKtSWJkOSClZXzsdy=> MlvUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
LAN-5 MkLqdWhVWyCjc4PhfS=> NW\ud2dJeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFzBUk02KGOnbHzz NGmwS5k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
Rh18 MVPxTHRUKGG|c3H5 M1LYVpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCUaEG4JINmdGy| NH3WNWc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SK-N-MC NU\QSpE3eUiWUzDhd5NigQ>? NGrWNldyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCFb37mbZJu[XSxcomgd4Nz\WWwIH\vdkBUUy2QLV3DJINmdGy| M3PCVFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
TC32 M{LVe5FJXFNiYYPzZZk> NI\ORpVyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCFb37mbZJu[XSxcomgd4Nz\WWwIH\vdkBVSzN{IHPlcIx{ NVP4TXlZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
insect M1LsSWZ2dmO2aX;uJIF{e2G7 M3\kbGlvcGmkaYTpc44hd2ZicnXjc41jcW6jboSgbJVu[W5iSHnzMZRi\2enZDDwPFVidHCqYT;wNVEx[WyyaHGgSVU1PUtibYX0ZY51KGW6cILld5Nm\CCrbjDpcpNm[3RiY3XscJMtKEmFNUCgQUAxNjBzMTFOwG0v NX;6U3hNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CwN|Q3ODdpPkOwNFM1PjB5PD;hQi=>
insect MVnGeY5kfGmxbjDhd5NigQ>? MnjhTY5pcWKrdHnvckBw\iC{ZXPvcYJqdmGwdDDoeY1idiCKaYOteIFo\2WmIIC4OYFteGijL4CxNVBidHCqYTDFOVQzUyCvdYThcpQh\XiycnXzd4VlKGmwIHnud4VkfCClZXzsd{whUUN3MDC9JFAvODJ7IN88UU4> NXnJNlhsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CwN|Q3ODdpPkOwNFM1PjB5PD;hQi=>
Sf21 NGPiOoJHfW6ldHnvckBie3OjeR?= MUmxJIhz NFLRW5FKdmirYnn0bY9vKG:oIILlZ49u[mmwYX70JIh2dWGwIH\1cIwudGWwZ4ToJG4ufGW{bXnuZYwhUGm|Nj30ZYdo\WRicEGxNIRmdHSjL4LlZ49u[mmwYX70JIh2dWGwIH\1cIwhdGWwZ4ToJJA5PWGucHjhJIV5eHKnc4Pl[EBqdiCkYXP1cI93cXK3czDpcoZm[3SnZDDT[lIyKGmwc3XjeEBk\WyuczD1d4lv\yCSSWCyJIF{KHO3YoP0doF1\SCvZXHzeZJm\CCjZoTldkAyKGi{IHL5JGFt\XijNkOzJHRz[WOncj3iZZNm\CCobIXvdoV{[2WwY3WgdI9t[XJuIFnDOVAhRSByLkGyOUDPxE1w M1jCTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyMEO0OlA4Lz5|MECzOFYxPzxxYU6=
MCF7 NV7WWnVzSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MnXMO|IhcHK| NGnzO|ZCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOgbIFz[m:{aX7nJHBKUzOFQTDFOVQ2UyCvdYThcpQh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvOjB4IN88UU4> MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODB|NE[wO{c,OzByM{S2NFc9N2F-
Sf21 MnvWSpVv[3Srb36gZZN{[Xl? MnziNUBpeg>? NVrUZm5DUW6qaXLpeIlwdiCxZjDy[YNwdWKrbnHueEBpfW2jbjDmeYxtNWynbnf0bEBPNXSncn3pcoFtKEirc{[teIFo\2WmIICxNVBj\XSjL4LlZ49u[mmwYX70JIh2dWGwIH\1cIwhdGWwZ4ToJJA5PWGucHjhJIV5eHKnc4Pl[EBqdiCkYXP1cI93cXK3czDpcoZm[3SnZDDT[lIyKGmwc3XjeEBk\WyuczD1d4lv\yCSSWCyJIF{KHO3YoP0doF1\SCvZXHzeZJm\CCjZoTldkAyKGi{IHL5JGFt\XijNkOzJHRz[WOncj3iZZNm\CCobIXvdoV{[2WwY3WgdI9t[XKrLDDJR|UxKD1iMD6yN|Qh|ryPLh?= M2[4WVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyMEO0OlA4Lz5|MECzOFYxPzxxYU6=
T47D NHTM[pdCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MUW3NkBpenN? NUi0OWtOSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDUOFdFKGOnbHzzJIhiemKxcnnu[{BRUTONQ1GgTFExPDeUIH31eIFvfCCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOC5{OE[g{txONg>? MnjSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzByM{S2NFcoRjNyMEO0OlA4RC:jPh?=
PC3 MkDxSpVv[3Srb36gZZN{[Xl? MnHXNkBpenN? MUTJcohq[mm2aX;uJI9nKFCLM1ugbY4hcHWvYX6gVGM{KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDBT3QheGixc4Doc5J6dGG2aX;uJIF1KFOnckS3N{Bu\WG|dYLl[EBi\nSncjCyJIhzeyCkeTDmcJVwemW|Y3XuZ4Uh[XO|YYmsJGlEPTBiPTCwMlM3PSEQvF2u NV3BemxpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CwN|Q3ODdpPkOwNFM1PjB5PD;hQi=>
HT-29 MmHER4VtdCCleXPs[UBie3OjeR?= MkfsNE4yOTFidH:gN{B2VQ>? Moi3NlQhcHK| NIXFfGRE\WyuIHP5Z4xmKGG{cnXzeEBqdiCqdX3hckBJXC1{OTDj[YxteyCjc4Pld5Nm\CCjczDhZ4N2dXWuYYTpc44h[XRiR{KvUUBxcGG|ZTDheEAxNjFzMTD0c{A{KHWPIHHmeIVzKDJ2IHjyd{BjgSCycn;wbYRqfW1iaX;kbYRmKHO2YXnubY5oKGKjc3XkJIZtd3diY4n0c41mfHK7 MmfPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzByM{S2NFcoRjNyMEO0OlA4RC:jPh?=
A2058 NXPib5h2TnWwY4Tpc44h[XO|YYm= MVWxJIhz M{\n[mlvcGmkaYTpc44hd2ZiVF;SR|IhcW5iaIXtZY4hSTJyNUigZ4VtdHNiYYPz[ZN{\WRiYYOg[IVkemWjc3WgbY4hWEuEL1HreEBxcG:|cHjvdplt[XSrb36gZZQhW2W{NEezJIFnfGW{IEGgbJIh[nliV3XzeIVzdiCkbH;0JIFv[Wy7c3nzMEBKSzVyIE2gNE41OTZizszNMi=> NF;hXFA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MEO1PVAxOyd-M{CzOVkxODN:L3G+
A2058 MlntSpVv[3Srb36gZZN{[Xl? MmThNUBpeg>? M4Th[2lvcGmkaYTpc44hd2ZiVF;SR|EhcW5iaIXtZY4hSTJyNUigZ4VtdHNiYYPz[ZN{\WRiYYOg[IVkemWjc3WgbY4hWzZicHjvd5Bpd3K7bHH0bY9vKGG2IGPldlI{PS9{M{[gZYZ1\XJiMTDodkBjgSCZZYP0[ZJvKGKub4SgZY5idHm|aYOsJGlEPTBiPTCwMlU2OyEQvF2u NVnFT4I4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CzOVkxODNpPkOwN|U6ODB|PD;hQi=>

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
p-AKT (T308) / p-AKT (S473) / AKT; 

PubMed: 27283525     


Left western blots showing levels of pAkt (T308), pAkt (S473) and total Akt in U87 cells exposed to buparlisib for 72 h. Right densitometric assessment of western blots, showing relative changes in phosphorylation.

p-FOXO3a (S253) / FOXO3a; 

PubMed: 28036259     


Cells were treated with 0.5 μM BKM120 for 24 h and cell lysates were immunoblotted with the indicated antibodies. Actin was used as the loading control.

Nuclear NF-κB p65 / NF-κB p65; 

PubMed: 26673665     


Western blots show BKM120 downregulating pAKT, nuclear NF-κB p65 and total NF-κB p65 in MDR and their parental cells. β-actin was used as a loading control for pAKT, AKT and total NF-κB p65. Lamin B was used as a loading control for nuclear NF-κB p65. 

p-ERK / ERK / LC3; 

PubMed: 27572309     


The indicated cell lines were exposed to different concentrations of BKM120 as indicated for 8 h A. or with 2 μM BKM120 for the indicated times B. The cells were then harvested for preparation of whole-cell protein lysates and subsequent Western blot analysis to detect the given proteins.

p-STAT3 / STAT3 / p-ERK / ERK / p-S6; 

PubMed: 29928341     


Western blot analysis of H460 and H2126 cell lysates using specific antibodies to phosphorylated or total proteins of STAT3, ERK1/2, AKT, S6 or GAPDH (loading control). The cells were treated with increasing concentrations of BKM120 for 24 h.

p-MET / MET; 

PubMed: 29928341     


The expression of phosphorylated or total forms of MET protein was analyzed by western blotting. 

27283525 28036259 26673665 27572309 29928341
Immunofluorescence
FOXO3a; 

PubMed: 28036259     


Cells were cultured on coverslips to approximately 60% confluency and then treated with 1 μM BKM120 for an additional 24 h. Immunofluorescence staining was performed using an anti-FOXO3a antibody and the nuclei were stained with DAPI. Scale bar, 20 μm.

28036259
Growth inhibition assay
Cell viability; 

PubMed: 26673665     


Dose-response curves were used to calculate the IC50 of BKM120 for MCs of MCF-7/A02 cells (upper) and CALDOX cells (lower).

26673665
体内研究 BKM120按30, 60, 或100 mg/kg剂量作用于A2780移植瘤,完全抑制pAKTser473。BKM120按 30和 60 mg/kg剂量作用于U87MG神经胶质瘤模型,显示抗癌活性。[1]BKM120每天按5μM/kg剂量处理具有持久生命力的ARP1 SCID鼠模型,导致肿瘤体积和K链水平明显降低。[2]

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

激酶实验:[2]
- 合并

PI3K 生化实验(ATP 消耗实验):

BKM120溶于DMSO中,按每孔1.25 µL直接加到黑色384孔板上。开始反应, 25 µL 10nM PI3K和5 µg/mL 1-α-磷酸肌醇(PI)加到实验 buffer (10 mM Tris pH 为7.5, 5 mM MgCl2, 20 mM NaCl, 1 mM DTT,及0.05% CHAPS),然后加到每孔中,随后在实验buffer中加入25 µL 2 µM ATP。反应进行直到50% ATP被消耗,然后加入25 µL KinaseGlo溶液终止反应。终止的反应温育5分钟,然后通过荧光测定残留的ATP。
细胞实验:[1]
- 合并
  • Cell lines: A2780细 胞
  • Concentrations: 0-6.6 μM
  • Incubation Time: 3天
  • Method: A2780细胞培养在含10% FBS,L-谷氨酸,丙酮酸钠和抗生素的DMEM培养基上。细胞按每孔103个细胞的密度接种在相同培养基上,温育3到5小时。稀释溶于20 mM DMSO中的BKM120。2 µL稀释的BKM120溶液加到细胞培养基上, (浓度为0-6.6 µM)。等体积(100 µL)溶液加到96孔板中,在37oC下温育3天。使用Trilux读取荧光值而测定抑制细胞增殖的效果
    (Only for Reference)
动物实验:[1]
- 合并
  • Animal Models: 携带U87MG 和A2780移植瘤的雌性裸鼠
  • Dosages: ~60 mg/kg
  • Administration: 每天口服处理
    (Only for Reference)

溶解度 (25°C)

体外 DMSO 82 mg/mL (199.8 mM)
Ethanol 2 mg/mL (4.87 mM)
Water Insoluble
体内 从左到右依次将纯溶剂加入产品,现配现用(数据来自Selleck实验检测而非文献):
5% DMSO+30% PEG 300+ddH2O
15mg/mL

* 溶解度检测是由Selleck技术部门检测的,可能会和文献中提供的溶解度有所差异,这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据

分子量 410.39
化学式

C18H21F3N6O2

CAS号 944396-07-0
储存条件 粉状
溶于溶剂
别名 NVP-BKM120

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % ddH2O
计算重置

计算器

摩尔浓度计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

  • 质量
    浓度
    体积
    分子量

*在配置溶液时,请务必参考Selleck产品标签上、MSDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。

稀释计算器

稀释计算器

用本工具协助配置特定浓度的溶液,使用的计算公式为:

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入 输出 )

  • C1
    V1
    C2
    V2

在配置溶液时,请务必参考Selleck产品标签上、MSDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。.

连续稀释计算器方程

  • 连续稀释

  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量计算器

分子量计算器

通过输入化合物的化学式来计算其分子量:

总分子量:g/mol

注:化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量 浓度 体积 分子量
计算

临床试验信息

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04338399 Not yet recruiting Drug: Buparlisib & Paclitaxel Head and Neck Cancer Adlai Nortye Biopharma Co. Ltd. July 31 2020 Phase 3
NCT02614508 Terminated Drug: Buparlisib|Drug: Ibrutinib|Biological: Ofatumumab Recurrent Chronic Lymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Small Lymphocytic Lymphoma Emory University|Novartis January 2016 Phase 1
NCT01613677 Withdrawn Drug: BKM120 Treatment for Metastatic or Locally Advanced Cervical Cancer Novartis Pharmaceuticals|Novartis November 2015 Phase 2

技术支持

在订购、运输、储存和使用我们的产品的任何阶段,您遇到的任何问题,均可以通过拨打我们的热线电话400-668-6834,或者技术支持邮箱tech@selleck.cn,直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题,请给我们留言。

  • * 必填项

PI3K Signaling Pathway Map

PI3K Inhibitors with Unique Features

相关PI3K产品

Tags: 购买Buparlisib (BKM120) | Buparlisib (BKM120)供应商 | 采购Buparlisib (BKM120) | Buparlisib (BKM120)价格 | Buparlisib (BKM120)生产 | 订购Buparlisib (BKM120) | Buparlisib (BKM120)代理商
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID